Cabergolinum [Latin] en es it fr

Cabergolinum [Latin] Brand names, Cabergolinum [Latin] Analogs

Cabergolinum [Latin] Brand Names Mixture

  • No information avaliable

Cabergolinum [Latin] Chemical_Formula


Cabergolinum [Latin] RX_link

Cabergolinum [Latin] fda sheet

Cabergolinum [Latin] msds (material safety sheet)

Cabergolinum [Latin] Synthesis Reference

No information avaliable

Cabergolinum [Latin] Molecular Weight

451.604 g/mol

Cabergolinum [Latin] Melting Point

102 - 104 oC

Cabergolinum [Latin] H2O Solubility


Cabergolinum [Latin] State


Cabergolinum [Latin] LogP


Cabergolinum [Latin] Dosage Forms

Tablets for oral administration (0.5 mg)

Cabergolinum [Latin] Indication

For the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas.

Cabergolinum [Latin] Pharmacology

Cabergoline is a dopamine receptor agonist and uncategorized drug which suppresses the production of prolactin in pituitary gland. It is an ergot-derivative. It has at times been used as an adjunct to SSRI antidepressants as there is some evidence that it counteracts certain side effects of those drugs such as reduced libido and anorgasmia. It also has been suggested online that it has a possible recreational use in reducing or eliminating the male refractory period.

Cabergolinum [Latin] Absorption

First-pass effect is seen, however the absolute bioavailability is unknown.

Cabergolinum [Latin] side effects and Toxicity

Overdosage might be expected to produce nasal congestion, syncope, or hallucinations.

Cabergolinum [Latin] Patient Information

Cabergolinum [Latin] Organisms Affected

Humans and other mammals